Horizon Therapeutics Usa
UEI: SK1UK7S74GB3
• CAGE: 6TDL9
Overview
Parent Awardee
Company Description
We're Horizon, a global biotechnology company driven by a simple idea: we believe that science and compassion must work together to transform lives.
Name
Horizon Therapeutics Usa
Website
Headquarters
Deerfield, IL
United States
United States
Most Recent Award
Feb. 28, 2025
Calculating
Federal contract recipient
HORIZON THERAPEUTICS USA, INC.
dba HORIZON THERAPEUTICS USA INC
(UEI SK1UK7S74GB3, CAGE 6TDL9)
is headquartered in Deerfield IL.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in June 2005 and
federally registered in
November 2012.
Federal Award Analysis
Horizon Therapeutics Usa federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
HORIZON THERAPEUTICS USA, INC.
DBA
HORIZON THERAPEUTICS USA INC
UEI
SK1UK7S74GB3
CAGE Code
6TDL9
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 22, 2005
Initial Registration
Nov. 13, 2012
Last Registration
April 10, 2026
Registration Activation
April 14, 2025
Registration Expiration
April 10, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Horizon Therapeutics Usa
GSA Schedules and Price Lists
- Horizon Therapeutics Usa
- PoP: 8/14/19 - 9/30/25 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $5,747,814